The Journal of Practical Medicine >
Effect of desflurane post⁃conditioning on myocardial protection in patients undergoing cardiac surgery under cardiopulmonary bypass
Received date: 2023-06-08
Online published: 2024-04-08
Objective To observe and evaluate the protective effect of desflurane post?conditioning on myocardial injury during cardiopulmonary bypass and its influence on patients' postoperative recovery. Methods A total of 200 patients in need of cardiac surgery were selected as the experimental subjects, who were aged from 20 to 65 years old, and divided into ASA Ⅱ-Ⅲ and NYHA Ⅱ-Ⅲ by endotracheal intubation and extracorporeal circulation method under general anesthesia. The patients were randomly divided into desflurane post?treatment group (experimental group, group D) and control group (group C) after selection. With the successive opening of the aorta and superior vena cava, group D were given 5% desflurane by inhalation with mechanical ventilation. While group C inhaled pure oxygen without inhaling desflurane. The depth of intraoperative anesthesia was maintained between 40 ~ 50 during the operation. Radial artery blood was collected from patients in 24 h before surgery (T0), immediately after intubation (T1), and 1 h(T2), 6 h (T3), 12 h (T4) and 24 h (T5)after aortic opening to achieve the determination of troponin I (cTnI) and creatine kinase isoenzyme MB (CK?MB).On the premise of obtaining the informed consent of the patient, about 50 mg of right atrial appendage tissue was collected before aortic intubation (T1.5) and 1 hour after aortic opening (T2) to determine the apoptosis rate. Results (1)cTnI in group C at the time of T2, T3, T4 and T5 was apparently higher than group D (P < 0.05). (2)CK?MB in group C at the time of T3 was apparently higher than group D (P < 0.05). (3)The myocardial tissue results showed that there was a lower apoptosis rate in experimental group at the time of T2 (P < 0.05). Conclusion Desflurane post?conditioning has a myocardial protective effect during cardiac surgery under cardiopulmonary bypass.
Xiangmi HUANG , Ying CHEN , Deming WANG , Kunpeng WU . Effect of desflurane post⁃conditioning on myocardial protection in patients undergoing cardiac surgery under cardiopulmonary bypass[J]. The Journal of Practical Medicine, 2024 , 40(6) : 838 -843 . DOI: 10.3969/j.issn.1006-5725.2024.06.018
| 1 | GUERRERO-ORRIACH J L, CARMONA-LUQUE M D, GONZALEZ-ALVAREZ L. Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress[J]. Int J Mol Sci,2022,23(3):1360. doi:10.3390/ijms23031360 |
| 2 | PAGEL S P, CRYSTAL J G. The Discovery of Myocardial Preconditioning Using Volatile Anesthetics: A History and Contemporary Clinical Perspective[J]. J Cardiothorac Vasc Anesth,2018,32(3):1112-1134. doi:10.1053/j.jvca.2017.12.029 |
| 3 | LANDONI G, LOMIVOROTOV V V, NIGRO NETO C, et al. Volatile Anesthetics versus Total Intravenous Anesthesia for Cardiac Surgery[J]. N Engl J Med,2019,380(13):1214-1225. |
| 4 | LOTZ C, STUMPNER J, SMUL M T. Sevoflurane as opposed to propofol anesthesia preserves mitochondrial function and alleviates myocardial ischemia/reperfusion injury[J]. Biomed Pharmacother,2020,129:110417. doi:10.1016/j.biopha.2020.110417 |
| 5 | AVIDAN M S, JACOBSOHN E, GLICK D, et al. Prevention of intraoperative awareness in a high-risk surgical population[J]. N Engl J Med,2011,365(7):591-600. doi:10.1056/nejmoa1100403 |
| 6 | HUANG Y H, WU Z F, LEE M S,et al. Propofol-basedtotal intravenous anesthesia is associated with better survival than desfluraneanesthesia in glioblastoma surgery[J]. PLoS One,2021,16(8):e0255627. doi:10.1371/journal.pone.0255627 |
| 7 | KANGHUI K, MEE S J. Desflurane and remifentanil anesthesia in a child with citrin deficiency: A case report[J]. Medicine,2022,101(9):e28954. doi:10.1097/md.0000000000028954 |
| 8 | ALESSANDRA F, FILIPPO T, CECILIA R, et al. Cardioplegia between Evolution and Revolution: From Depolarized to Polarized Cardiac Arrest in Adult Cardiac Surgery[J]. J Clin Med,2021,10(19):4485. doi:10.3390/jcm10194485 |
| 9 | ZANGRILLO A, LOMIVOROTOV V V, PASYUGA V V, et al. Effect of Volatile Anesthetics on Myocardial Infarction After Coronary Artery Surgery: A Post Hoc Analysis of a Randomized Trial[J]. J Cardiothorac Vasc Anesth,2022,36(8PA):2454-2462. doi:10.1053/j.jvca.2022.01.001 |
| 10 | LUIS J G, DOLORES M C, LAURA G. Heart Failure after Cardiac Surgery: The Role of Halogenated Agents, Myocardial Conditioning and Oxidative Stress[J]. Int J Mol Sci,2022,23(3):1360. doi:10.3390/ijms23031360 |
| 11 | 万子琳,李亚雄,王小燕,等.全程吸入不同浓度七氟烷对冠状动脉旁路移植术患者心肌保护作用及炎症细胞因子的影响[J].实用医学杂志,2020,36(8):1096-1101. doi:10.3969/j.issn.1006-5725.2020.08.022 |
| 12 | TAKAHIRO T, ATSUSHI M, AKIRA I, et al. Desflurane and sevoflurane concentrations in blood passing through the oxygenator during cardiopulmonary bypass: a randomized prospective pilot study[J]. J Anesth,2020,34(6):904-911. doi:10.1007/s00540-020-02844-1 |
| 13 | 陈莹,吴昆鹏,王德明.地氟醚后处理对二尖瓣置换术后心功能的保护作用[J].广东医学,2019,40(3):395-398,402. |
| 14 | ZHIPENG Y, LI W,JUN C, et al. Electrochemical strategies for the detection of cTnI[J]. Analyst,2021,146(18):5474-5495. doi:10.1039/d1an00808k |
| 15 | PONFERRADA R A, FERNANDEZ R A, SANTIAGO-FERNANDEZ C, et al. NGS of microRNAs Involved in Cardioprotection Induced by Sevoflurane Compared to Propofol in Myocardial Revascularization Surgery: The ACDHUVV-16 Clinical Trial[J]. Curr Med Chem,2021,28(20):4074-4086. |
| 16 | QIN H, ZHOU J. Myocardial Protection by Desflurane: From Basic Mechanisms to Clinical Applications[J]. J Cardiovasc Pharmacol,2023,82(3):169-179. doi:10.1097/fjc.0000000000001448 |
| 17 | 李林,殷月,王晨晨,等. 氢气抑制TL1A/DR3通路对兔肢体缺血-再灌注后心肌细胞凋亡的影响[J]. 实用医学杂志,2023,39(16):2037-2042. doi:10.3969/j.issn.1006-5725.2023.16.005 |
| 18 | GUARRACINO F, LANDONI G, TRITAPEPE L, et al. Myocardial Damage Prevented by Volatile Anesthetics: A Multicenter Randomized Controlled Study[J]. J Cardiothorac Vasc Anesth, 2006,20(4):477-483. doi:10.1053/j.jvca.2006.05.012 |
/
| 〈 |
|
〉 |